🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Epidural space localization using loss of resistance technique with air (AL...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT02792933
Treatments Being Tested
Despite advances in medications, allergic diseases, including allergic asth...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2013-01
Trial ID
NCT01711593
Treatments Being Tested
Using protective or combat garments under heavy heat stress conditions, dur...
Status
Completed
Location
Sheba medical center
Start Date
2015-06
Trial ID
NCT02442947
Treatments Being Tested
This phase III trial compares the effect of sentinel lymph node mapping to ...
Status
Recruiting
Location
George Washington University Medical Center
Start Date
2022-12-07
Trial ID
NCT05646316
The objective of this study is to evaluate tolerability, safety and efficac...
Status
Completed
Location
Dipartimento "Organi di Senso" Università La Sapienza- Policlinico Umberto I
Start Date
2015-06-26
Trial ID
NCT02507934
Treatments Being Tested
Medication is an efficacious treatment strategy for adolescents with attent...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2020-06-01
Trial ID
NCT04386096
The goal of this phase 0 proof-of concept study is to measure the therapeut...
Status
Unknown
Location
Division of Nuclear Medicine, University Hospital Basel
Start Date
2023-03-28
Trial ID
NCT05359146
Treatments Being Tested
In this research study, the investigators aim to test the usability and eff...
Status
Active Not Recruiting
Location
Spaulding Rehabilitation Hospital Boston
Start Date
2021-07-23
Trial ID
NCT04625127
In order to assess the potential impact of steady state BI 425809 on CYP3A ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-03-18
Trial ID
NCT05258110
Treatments Being Tested
The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-01-12
Trial ID
NCT03004404